IRES-dependent translation of shorter p53 isoforms is affected by mutations in p53

Lacerda, Rafaela; Neves, Ana Rita; Maruo, M; Romão, Luísa; Matsuda, M; Candeias, Marco

http://hdl.handle.net/10400.18/5114

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Abstract Rafaela SPGH 2017.pdf		166.96 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Full-length p53 (FLp53) is a tumour suppressor protein that has been considered a master regulator of many cellular functions. Several isoforms have been described for p53 so far and some of the functions of shorter p53 isoforms have been elucidated and they are different from and complement FLp53 activity. p53 is the most commonly mutated gene in cancer and depending on its mutation status p53 may act as a tumour suppressor or a proto-oncogene. Recently, we have shown that the most common p53 cancer mutants express a larger number and higher levels of shorter p53 protein isoforms that are translated from the mutated FLp53 mRNA (Candeias et al. EMBO R. 2016). Also, we found that cells expressing these shorter p53 isoforms exhibit mutant p53 “gain-of-function” cancer phenotypes, such as enhanced cell survival, proliferation, invasion and adhesion, altered mammary tissue architecture and invasive cell structures. Here, we found that some of these mutations affect the function of an Internal Ribosome Entry Site (IRES) in p53 mRNA. We investigated which mutations influence — by altering IRES structure and function — IRES-dependent translation of shorter p53 isoforms and to what extent this may lead to the onset or progression of some types of tumours.